Question 85

A Master Formulation Record for a compounded medication must include information regarding the beyond-use date.

A Master Formulation Record must include the beyond-use date as this is critical for ensuring the safety and efficacy of compounded medications. The beyond-use date indicates the time frame in which the compounded medication can be safely used.

A) beyond-use date

This option is correct because the beyond-use date is a fundamental component of a Master Formulation Record. It ensures that the compounded medication is used within a safe period, thus minimizing the risk of degradation and maintaining its therapeutic effectiveness.

B) patient name

This option is incorrect because while patient-specific information is essential in clinical settings, the Master Formulation Record focuses on the compounding process and does not require the inclusion of individual patient names.

C) ingredient cost

This option is not relevant to the Master Formulation Record as it does not pertain to the formulation or safety of the compounded medication. The cost of ingredients is important for financial considerations but does not affect the formulation documentation itself.

D) reorder quantity

This option is incorrect because reorder quantity is more related to inventory management rather than the formulation specifics outlined in a Master Formulation Record. The document should concentrate on the formulation and stability aspects rather than stock levels.

Conclusion

The inclusion of the beyond-use date in a Master Formulation Record is essential for maintaining the safety and effectiveness of compounded medications, ensuring they are used within an appropriate time frame. Other options, such as patient name, ingredient cost, and reorder quantity, do not directly pertain to the formulation process and thus are not necessary components of this important record.